These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23907518)

  • 41. Repeated isolated limb perfusion in melanoma patients with recurrent in-transit metastases.
    Deroose JP; Grünhagen DJ; Eggermont AM; Verhoef C
    Melanoma Res; 2015 Oct; 25(5):427-31. PubMed ID: 26110555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural history and selective management of in transit melanoma.
    Wong JH; Cagle LA; Kopald KH; Swisher SG; Morton DL
    J Surg Oncol; 1990 Jul; 44(3):146-50. PubMed ID: 2370798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of regional chemotherapy in the management of extremity soft tissue malignancies.
    Smith HG; Hayes AJ
    Eur J Surg Oncol; 2016 Jan; 42(1):7-17. PubMed ID: 26382102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolated limb perfusion for melanoma.
    Kroon BB; Noorda EM; Vrouenraets BC; van Slooten GW; Nieweg OE
    Surg Oncol Clin N Am; 2008 Oct; 17(4):785-94, viii-ix. PubMed ID: 18722918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Managing in-transit melanoma metastases in the new era of effective systemic therapies for melanoma.
    Read RL; Thompson JF
    Expert Rev Clin Pharmacol; 2019 Dec; 12(12):1107-1119. PubMed ID: 31687857
    [No Abstract]   [Full Text] [Related]  

  • 46. Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion.
    Di Filippo F; Calabrò A; Giannarelli D; Carlini S; Cavaliere F; Moscarelli F; Cavaliere R
    Cancer; 1989 Jun; 63(12):2551-61. PubMed ID: 2720604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Local and intralesional therapy of in-transit melanoma metastases.
    Testori A; Faries MB; Thompson JF; Pennacchioli E; Deroose JP; van Geel AN; Verhoef C; Verrecchia F; Soteldo J
    J Surg Oncol; 2011 Sep; 104(4):391-6. PubMed ID: 21858834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Contemporary Role of Major Amputation in the Management of Advanced Limb Melanoma.
    Read RL; Stalley P; Thompson JF
    Ann Surg Oncol; 2015 Nov; 22(12):4067-72. PubMed ID: 25712799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma.
    Noorda EM; Takkenberg B; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Hart GA; Kroon BB
    Ann Surg Oncol; 2004 May; 11(5):491-9. PubMed ID: 15078633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma.
    Möller MG; Salwa S; Soden DM; O'Sullivan GC
    Expert Rev Anticancer Ther; 2009 Nov; 9(11):1611-30. PubMed ID: 19895245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma.
    Paulsen IF; Chakera AH; Drejøe JB; Klyver H; Dahlstrøm K; Oturai PS; Mortensen J; Hesse B; Schmidt G; Drzewiecki K
    Dan Med J; 2014 Jan; 61(1):A4741. PubMed ID: 24393586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Locoregional management of in-transit metastasis in melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline.
    Wright FC; Kellett S; Hong NJL; Sun AY; Hanna TP; Nessim C; Giacomantonio CA; Temple-Oberle CF; Song X; Petrella TM
    Curr Oncol; 2020 Jun; 27(3):e318-e325. PubMed ID: 32669939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolated hyperthermia chemotherapy perfusion for limb melanoma.
    Krementz ET; Sutherland CM; Muchmore JH
    Surg Clin North Am; 1996 Dec; 76(6):1313-30. PubMed ID: 8977553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Results of isolated hyperthermic extremity perfusion in soft tissue sarcomas within the scope of a multimodality treatment concept].
    Schwarzbach M; Lehnert T; Willeke F; Hinz U; Herfarth C
    Chirurg; 1996 Dec; 67(12):1237-43. PubMed ID: 9081786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The application of hyperthermia in regional chemotherapy.
    Di Filippo F; Anzà M; Rossi CR; Cavaliere F; Botti C; Lise M; Garinei R; Giannarelli D; Vasselli S; Zupi G; Cavaliere R
    Semin Surg Oncol; 1998; 14(3):215-23. PubMed ID: 9548604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calculating regional tissue volume for hyperthermic isolated limb perfusion: Four methods compared.
    Cecchin D; Negri A; Frigo AC; Bui F; Zucchetta P; Bodanza V; Gregianin M; Campana LG; Rossi CR; Rastrelli M
    Eur J Surg Oncol; 2016 Dec; 42(12):1898-1905. PubMed ID: 27005884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are locoregional cutaneous metastases in melanoma predictable?
    Borgstein PJ; Meijer S; van Diest PJ
    Ann Surg Oncol; 1999; 6(3):315-21. PubMed ID: 10340893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional chemotherapy by isolation-perfusion.
    McBride CM; McMurtrey MJ; Copeland EM; Hickey RC
    Int Adv Surg Oncol; 1978; 1():1-9. PubMed ID: 553035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Regional chemotherapy--perfusion of the extremities].
    Meyer T; Göhl J
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():200-4. PubMed ID: 11824246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
    Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
    Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.